LSKL, Inhibitor of Thrombospondin TSP–1 cas: (283609-79-0)

nazwa: LSKL, Inhibitor of Thrombospondin TSP–1

nr katalogowy: GC32728-10

cas: 283609-79-0

producent: GLPBio

opakowanie: 10mg

cena: 971,48 [Pln] (bez rabatu)

wyszukaj podobne produkty: 283609-79-0


szczegóły:

Formula: C21H42N6O5. Molecular weight: 458,6. Solubility: DMSO : ≥ 100 mg/mL (218.05 mM). Storage: Store at -20°C. Synonym: LSKL, Inhibitor of Thrombospondin TSP-1 is a latency-associated protein (LAP)-TGFβ derived tetrapeptide and a competitive TGF-β1 antagonist. LSKL, Inhibitor of Thrombospondin TSP-1 inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin TSP-1 suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-β1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin TSP-1 can readily crosse the blood-brain barrier..

właściwości

czystość: No data

czas dostawy: Do potwierdzenia przez Chemat